Cargando…
Successful Treatment of Oral Crohn’s Disease by Ustekinumab
We report on a Crohn’s disease patient with severe dysphagia and malnutrion due to Crohn’s-related cheilitis and tonsillitis that was refractory to steroids, anti-TNF, and anti-integrin therapy but was successfully treated with ustekinumab.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186322/ https://www.ncbi.nlm.nih.gov/pubmed/31907551 http://dx.doi.org/10.1093/ibd/izz321 |
| _version_ | 1784724906844356608 |
|---|---|
| author | Jukema, Jelmer B Brandse, Johannan F de Boer, Nanne K H |
| author_facet | Jukema, Jelmer B Brandse, Johannan F de Boer, Nanne K H |
| author_sort | Jukema, Jelmer B |
| collection | PubMed |
| description | We report on a Crohn’s disease patient with severe dysphagia and malnutrion due to Crohn’s-related cheilitis and tonsillitis that was refractory to steroids, anti-TNF, and anti-integrin therapy but was successfully treated with ustekinumab. |
| format | Online Article Text |
| id | pubmed-9186322 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91863222022-06-13 Successful Treatment of Oral Crohn’s Disease by Ustekinumab Jukema, Jelmer B Brandse, Johannan F de Boer, Nanne K H Inflamm Bowel Dis Letters to the Editor We report on a Crohn’s disease patient with severe dysphagia and malnutrion due to Crohn’s-related cheilitis and tonsillitis that was refractory to steroids, anti-TNF, and anti-integrin therapy but was successfully treated with ustekinumab. Oxford University Press 2020-03 2020-01-07 /pmc/articles/PMC9186322/ /pubmed/31907551 http://dx.doi.org/10.1093/ibd/izz321 Text en © 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letters to the Editor Jukema, Jelmer B Brandse, Johannan F de Boer, Nanne K H Successful Treatment of Oral Crohn’s Disease by Ustekinumab |
| title | Successful Treatment of Oral Crohn’s Disease by Ustekinumab |
| title_full | Successful Treatment of Oral Crohn’s Disease by Ustekinumab |
| title_fullStr | Successful Treatment of Oral Crohn’s Disease by Ustekinumab |
| title_full_unstemmed | Successful Treatment of Oral Crohn’s Disease by Ustekinumab |
| title_short | Successful Treatment of Oral Crohn’s Disease by Ustekinumab |
| title_sort | successful treatment of oral crohn’s disease by ustekinumab |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186322/ https://www.ncbi.nlm.nih.gov/pubmed/31907551 http://dx.doi.org/10.1093/ibd/izz321 |
| work_keys_str_mv | AT jukemajelmerb successfultreatmentoforalcrohnsdiseasebyustekinumab AT brandsejohannanf successfultreatmentoforalcrohnsdiseasebyustekinumab AT deboernannekh successfultreatmentoforalcrohnsdiseasebyustekinumab |